NCCI: GLP-1 Spending Rises 39% Annually, Remains a Fraction of Total Costs

The National Council on Compensation Insurance, as part of its recently launched initiative that aims to answer timely questions from system users, said spending on GLP-1 medications increased by about 39% per year since 2021 but still accounts for just a fraction of total medical costs. "Despite continued growth, GLP-1 use in workers' compensation remains extremely limited, both in terms of the share of claims with these drugs and the overall volume of losses observed," NCCI said in the latest installment of its "Asked & Answered" series. "We don’t expe...